M28 Capital Management LP Stoke Therapeutics, Inc. Transaction History

M28 Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$7.93 - $13.82 $1.48 Million - $2.58 Million	-186,700 Reduced 35.04%	346,190 $3.68 Million
Q1 2023 May 12, 2023	BUY	$7.65 - $10.38 $382,500 - $519,000	50,000 Added 10.35%	532,890 $4.44 Million
Q4 2022 Feb 10, 2023	SELL	$7.07 - $15.69 $280,396 - $622,265	-39,660 Reduced 7.59%	482,890 $4.46 Million
Q3 2022 Nov 10, 2022	SELL	$12.56 - $22.53 $57,776 - $103,638	-4,600 Reduced 0.87%	522,550 $6.71 Million
Q4 2021 Feb 11, 2022	BUY	$18.11 - $30.72 $9.55 Million - $16.2 Million	527,150 New	527,150 $12.6 Million

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $367M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of M28 Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on M28 Capital Management LP with notifications on news.